This course presents and discusses the requirements and methods to enable and perform personalized dosimetry in nuclear medicine therapy. Learning Objectives The aim of this course is to provide tools and methods to implement personalized dosimetry in a clinical setup. Target Audience Nuclear medicine clinicians and medical physicists Suggested Readings "EANM enabling guide: how to […]
More information coming soon Learning Objectives Target Audience Faculty Registration Details
The course aims to provide the participants with basic knowledge regarding nuclear and molecular medical imaging in the neurological field. In particular, cerebral SPET and PET will be addressed. Learning Objectives Target Audience Nuclear medicine specialists with little or no experience in reading SPET and PET neurological imaging. Faculty Registration Details
The course is designed for Technologists and Nurses to enhance their expertise in applying radiopharmaceuticals for AD and MCI diagnosis in nuclear medicine. Participants will learn radiation protection principles, radiolabelling procedures, and waste management. The program also covers novel PET radiotracers for molecular diagnosis of neurocognitive disorders. Additionally, the course addresses patient and caregiver management […]
This self-paced online course will offer a comprehensive exploration of the anatomy, physiology, and diagnostic tools related to parathyroid glands disorders. The course will cover a range of topics, including the regulation of parathyroid hormone (PTH) secretion and his mechanisms of action, etiology, clinical manifestations, and notably the diagnostic approaches ( laboratory and imaging), and […]
This online course offers a comprehensive introduction to alpha therapy in nuclear medicine, with a focus on the fundamental principles and clinical applications of Alpha-Therapy in the fields of Radiopharmaceutical Sciences, Oncology and Dosimetry. Alpha Therapy is a cutting-edge cancer treatment using alpha radiation. It represents a form of targeted radionuclide therapy that uses alpha-emitting […]
The GMP guidelines provide minimum requirements that a manufacturer of radiopharmaceuticals must meet to assure that their products are consistently high in quality, from batch to batch, for clinical use. The Basics of cGMP is a 2 days on-site ESMIT course, providing guidance through EU-cGMP regulation for manufacturing, testing, and quality assurance of radiopharmaceuticals in order to […]
This webinar provides an overview of the diagnosis of cardiac amyloidosis in nuclear cardiology . Background information on amyloidosis in general is presented and typical disease manifestations are discussed. Furthermore, the significance of cardiac amyloidosis will be discussed in detail and possible therapeutic options will be explained. In this context, the relevance of quantification to […]
In nuclear medicine, diagnostic as well as therapeutic, radiopharmaceuticals are administered via an intravenous injection, in a majority of the procedures in a blood vessel at the crook of the arm or on the back of the hand. Occasionally, the injection fails, which results in the radiopharmaceutical ending up extravascularly. The consequence of this may […]
The purpose of this seminar is to provide a comprehensive overview of radionuclide therapy using alpha-emitting isotopes, focusing on their current clinical and preclinical applications. It will explore the unique advantages of alpha emitters, such as their high linear energy transfer and short path length, which allow for precise tumor cell killing with minimal damage […]
For performing the PET/CT examination, the administration of radiopharmaceutical as unavoidable for imaging with PET. Inversely, the administration of contrast agent to improve the quality of CT part of PET/CT as optional. The accurate intravenous administration of diagnostic radiopharmaceutical (and optionally of contrast agent) may be challenging in some cases, in particular in patients with […]
European School of Multimodality Imaging & Therapy (ESMIT)
Schmalzhofgasse 26
1060 Vienna
Austria
phone +43 1 890 44 27
e-mail esmit@eanm.org
